Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
20.85
+0.41 (1.97%)
Jun 17, 2025, 4:00 PM - Market closed
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 9 analysts that cover Acadia Healthcare Company stock have a consensus rating of "Buy" and an average price target of $47.94, which forecasts a 129.93% increase in the stock price over the next year. The lowest target is $28 and the highest is $75.
Price Target: $47.94 (+129.93%)
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 5 | 5 | 4 |
Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 9 | 10 | 10 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Hold Maintains $37 → $32 | Hold | Maintains | $37 → $32 | +53.48% | May 14, 2025 |
Barclays | Barclays | Hold Maintains $35 → $28 | Hold | Maintains | $35 → $28 | +34.29% | May 14, 2025 |
Keybanc | Keybanc | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +163.79% | May 14, 2025 |
Guggenheim | Guggenheim | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +72.66% | Apr 9, 2025 |
Mizuho | Mizuho | Hold Maintains $48 → $37 | Hold | Maintains | $48 → $37 | +77.46% | Mar 25, 2025 |
Financial Forecast
Revenue This Year
3.40B
from 3.15B
Increased by 7.83%
Revenue Next Year
3.69B
from 3.40B
Increased by 8.56%
EPS This Year
2.71
from 2.78
Decreased by -2.52%
EPS Next Year
3.06
from 2.71
Increased by 12.82%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.5B | 3.9B | 4.2B | ||
Avg | 3.4B | 3.7B | 4.0B | ||
Low | 3.2B | 3.5B | 3.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.0% | 14.1% | 13.1% | ||
Avg | 7.8% | 8.6% | 7.4% | ||
Low | 2.2% | 1.7% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.90 | 3.53 | 3.62 | ||
Avg | 2.71 | 3.06 | 3.32 | ||
Low | 2.45 | 2.37 | 2.78 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.2% | 30.2% | 18.5% | ||
Avg | -2.5% | 12.8% | 8.5% | ||
Low | -11.9% | -12.5% | -9.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.